Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2012

01.11.2012 | Maternal-Fetal Medicine

Do intrauterine growth restricted fetuses of the hypertensive and normotensive mothers differ from each other?

verfasst von: Huriye A. Parlakgumus, Cantekin Iskender, Pinar Caglar Aytac, Ebru Tarim

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate if normotensive and hypertensive patients with intrauterine growth restricted (IUGR) fetuses were different with respect to maternal and fetal characteristics and Doppler flow.

Methods

The records of patients with IUGR fetuses who had to be delivered before 34th gestational week because of fetal distress were examined. Early Doppler abnormalities were defined as increased umbilical artery resistance and redistribution of blood flow in the middle cerebral artery while late Doppler abnormalities were defined as the absence or reversal of umbilical artery blood flow and Doppler flow changes in venous Doppler. t Test, Chi-square test and Mann–Whitney U test were used for the comparison of data as appropriate. p < 0.05 was considered statistically significant.

Results

Thirty-six patients were hypertensive while 42 were normotensive. Gestational week at admission for hypertensive and normotensive groups (30.8 ± 3.6 vs. 32.3 ± 3.1) (p = 0.057), time to delivery (7.1 ± 12.6 vs. 4.3 ± 9.1 days) (p = 0.267) and gestational week at delivery (31.8 ± 3.1 vs. 32.9 ± 2.9) (p = 0.117) were similar. Birth weight was significantly lower (1242 ± 534 vs. 1516 ± 504 g) (p = 0.02) in the normotensive group. The frequency of having oligohydramnios (64.2 % for normotensive and 44.4 % for hypertensive patients) (p = 0.079) was similar in both groups. Early Doppler abnormalities were more common in hypertensive group (75 vs. 40.5 %) (p = 0.001) while late Doppler abnormalities were more common in normotensive group (25 vs. 59.5 %) (p = 0.001).

Conclusion

Birth weight was lower and late Doppler abnormalities were more common in the normotensive group while early Doppler abnormalities were more common in hypertensive group.
Literatur
1.
Zurück zum Zitat American College of Obstetrics and Gynecology Practice Bulletin 12 (2000) Intrauterine growth restriction American College of Obstetrics and Gynecology Practice Bulletin 12 (2000) Intrauterine growth restriction
2.
Zurück zum Zitat Mandruzzato G (2008) Intrauterine growth restriction (IUGR): guidelines for definition, recognition and management. Arch Perinat Med 14(4):7–8 Mandruzzato G (2008) Intrauterine growth restriction (IUGR): guidelines for definition, recognition and management. Arch Perinat Med 14(4):7–8
3.
Zurück zum Zitat Battaglia FC, Lubchenco LO (1967) A practical classification of newborn infants by weight and gestational age. J Pediatr 71:159PubMedCrossRef Battaglia FC, Lubchenco LO (1967) A practical classification of newborn infants by weight and gestational age. J Pediatr 71:159PubMedCrossRef
4.
Zurück zum Zitat Seeds JW, Peng T (1998) Impaired growth and risk of fetal death: is the tenth percentile the appropriate standard? Am J Obstet Gynecol 178(4):658PubMedCrossRef Seeds JW, Peng T (1998) Impaired growth and risk of fetal death: is the tenth percentile the appropriate standard? Am J Obstet Gynecol 178(4):658PubMedCrossRef
5.
Zurück zum Zitat Zhang J, Mikolajczyk R, Grewal J, Neta G, Klebanoff M (2011) Prenatal application of the individualized fetal growth reference. Am J Epidemiol 173(5):539PubMedCrossRef Zhang J, Mikolajczyk R, Grewal J, Neta G, Klebanoff M (2011) Prenatal application of the individualized fetal growth reference. Am J Epidemiol 173(5):539PubMedCrossRef
6.
Zurück zum Zitat Battin MR, McCowan LM, George-Haddad M, Thompson JM (2007) Fetal growth restriction and other factors associated with neonatal death in New Zealand. Aust N Z J Obstet Gynecol 47(6):457–463CrossRef Battin MR, McCowan LM, George-Haddad M, Thompson JM (2007) Fetal growth restriction and other factors associated with neonatal death in New Zealand. Aust N Z J Obstet Gynecol 47(6):457–463CrossRef
7.
Zurück zum Zitat Piper JM, Xenakis EM, McFarland M, Elliott BD, Berkus MD, Langer O (1996) Do growth-retarded premature infants have different rates of perinatal morbidity and mortality than appropriately grown premature infants? Obstet Gynecol 87(2):169–174PubMedCrossRef Piper JM, Xenakis EM, McFarland M, Elliott BD, Berkus MD, Langer O (1996) Do growth-retarded premature infants have different rates of perinatal morbidity and mortality than appropriately grown premature infants? Obstet Gynecol 87(2):169–174PubMedCrossRef
8.
Zurück zum Zitat Önderoğlu LS, Başaran A (2010) Placental insufficiency and fetal growth restriction. Turkiye Klinikleri J Gynecol Obstet Special Top 3(1):53–63 Önderoğlu LS, Başaran A (2010) Placental insufficiency and fetal growth restriction. Turkiye Klinikleri J Gynecol Obstet Special Top 3(1):53–63
9.
Zurück zum Zitat Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Báaqeel H et al (2006) World Health Organization Antenatal Care Trial Research Group. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 194(4):921–931PubMedCrossRef Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Báaqeel H et al (2006) World Health Organization Antenatal Care Trial Research Group. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 194(4):921–931PubMedCrossRef
10.
Zurück zum Zitat Ness RB, Sibai BM (2006) Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 195:40–49PubMedCrossRef Ness RB, Sibai BM (2006) Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 195:40–49PubMedCrossRef
11.
Zurück zum Zitat Axt R, Kordina A, Reitnauer K, Mink D, Schmidt W (1999) Immunohistochemical evaluation of apoptosis in placentae from normal and intrauterine growth restricted pregnancies. Clin Expert Gynecol 26:195–198 Axt R, Kordina A, Reitnauer K, Mink D, Schmidt W (1999) Immunohistochemical evaluation of apoptosis in placentae from normal and intrauterine growth restricted pregnancies. Clin Expert Gynecol 26:195–198
12.
Zurück zum Zitat Kaufmann P, Black S, Huppertz B (2003) Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69(1):1–7 Epub 2003 Mar 5. ReviewPubMedCrossRef Kaufmann P, Black S, Huppertz B (2003) Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69(1):1–7 Epub 2003 Mar 5. ReviewPubMedCrossRef
13.
Zurück zum Zitat Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM (2011) Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 7:467–474PubMed Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM (2011) Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 7:467–474PubMed
14.
Zurück zum Zitat Srinivas SK, Edlow AG, Neff PM, Sammel MD, Andrela CM, Elovitz MA (2009) Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension? J Perinatol 29(10):680–684PubMedCrossRef Srinivas SK, Edlow AG, Neff PM, Sammel MD, Andrela CM, Elovitz MA (2009) Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension? J Perinatol 29(10):680–684PubMedCrossRef
15.
Zurück zum Zitat Catow JM, Ness RB, Kip KE, Olsen J (2007) Risk of early or severe preeclampsia related to pre-existing conditions. Int J Epidemiol 36(2):412–419CrossRef Catow JM, Ness RB, Kip KE, Olsen J (2007) Risk of early or severe preeclampsia related to pre-existing conditions. Int J Epidemiol 36(2):412–419CrossRef
16.
Zurück zum Zitat Sibai BM, Ewell M, Lewine RJ, Klebanoff MA, Catalano PM et al (1997) Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 177:1003–1010PubMedCrossRef Sibai BM, Ewell M, Lewine RJ, Klebanoff MA, Catalano PM et al (1997) Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 177:1003–1010PubMedCrossRef
17.
Zurück zum Zitat Bradley RJ, Nicolaides KH, Brudenell JM (1998) Are all infants of diabetic mothers “macrosomic”? BMJ 297:1583–1584CrossRef Bradley RJ, Nicolaides KH, Brudenell JM (1998) Are all infants of diabetic mothers “macrosomic”? BMJ 297:1583–1584CrossRef
18.
Zurück zum Zitat Bernstein PS, Divon MY (1997) Etiologies of fetal growth restriction. Clin Obstet Gynecol 40:723–729PubMedCrossRef Bernstein PS, Divon MY (1997) Etiologies of fetal growth restriction. Clin Obstet Gynecol 40:723–729PubMedCrossRef
19.
Zurück zum Zitat McDonald AD, Armstrong BJ, Sloan M (1992) Cigarette, alcohol and coffee consumption and prematurity. Am J Public Health 82:87–90PubMedCrossRef McDonald AD, Armstrong BJ, Sloan M (1992) Cigarette, alcohol and coffee consumption and prematurity. Am J Public Health 82:87–90PubMedCrossRef
20.
Zurück zum Zitat Conde-Aguledo A, Althabe F, Belizan J, Kafury-Goeta A (1999) Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol 181:1026–1035CrossRef Conde-Aguledo A, Althabe F, Belizan J, Kafury-Goeta A (1999) Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol 181:1026–1035CrossRef
21.
Zurück zum Zitat Brosens IA (1977) Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynecol 4(3):573–593 Brosens IA (1977) Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynecol 4(3):573–593
22.
Zurück zum Zitat Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF et al (2005) Urinary placental growth factor and risk of preeclampsia. JAMA 293:77–85PubMedCrossRef Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF et al (2005) Urinary placental growth factor and risk of preeclampsia. JAMA 293:77–85PubMedCrossRef
23.
Zurück zum Zitat Sekizawa A, Jimbo M, Saito H, Iwasaki M, Matsuoka R, Okai T et al (2003) Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 188:480–484PubMedCrossRef Sekizawa A, Jimbo M, Saito H, Iwasaki M, Matsuoka R, Okai T et al (2003) Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 188:480–484PubMedCrossRef
24.
Zurück zum Zitat Richani K, Soto E, Romero R, Espinoza J, Tinnakom CH, Nien JK et al (2005) Preeclampsia and SGA differ in the maternal plasma complement split products profile. J Soc Gynecol Invest 12:148A Richani K, Soto E, Romero R, Espinoza J, Tinnakom CH, Nien JK et al (2005) Preeclampsia and SGA differ in the maternal plasma complement split products profile. J Soc Gynecol Invest 12:148A
25.
Zurück zum Zitat Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mörtl M, Beckmann MW, Lang U (2007) Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 29(4):407–413PubMedCrossRef Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mörtl M, Beckmann MW, Lang U (2007) Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 29(4):407–413PubMedCrossRef
26.
Zurück zum Zitat Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH (2008) Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction. Ultrasound Obstet Gynecol 32(5):682–686PubMedCrossRef Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH (2008) Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction. Ultrasound Obstet Gynecol 32(5):682–686PubMedCrossRef
27.
Zurück zum Zitat Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, Zwinderman AH, Robson SC, Bindels PJ, Kleijnen J, Khan KS (2008) Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 178(6):701–711 ReviewPubMedCrossRef Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, Zwinderman AH, Robson SC, Bindels PJ, Kleijnen J, Khan KS (2008) Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 178(6):701–711 ReviewPubMedCrossRef
Metadaten
Titel
Do intrauterine growth restricted fetuses of the hypertensive and normotensive mothers differ from each other?
verfasst von
Huriye A. Parlakgumus
Cantekin Iskender
Pinar Caglar Aytac
Ebru Tarim
Publikationsdatum
01.11.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2452-x

Weitere Artikel der Ausgabe 5/2012

Archives of Gynecology and Obstetrics 5/2012 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.